Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients

Re:Low-dose Hydroxychloroquine Therapy and Mortality in Hosp... by f154hfds on Tuesday August 25, 2020 @01:51PM (#24273985)

Thanks for the meta-analysis link! Looking at the other measures, it does mention HCQ in duration of symptoms.

> Hydroxychloroquine might be the most effective in reducing the duration of symptoms. Remdesivir has intermediate effectiveness and lopinavir-ritonavir could have intermediate effectiveness. The main limitations of the evidence are risk of bias and imprecision.

[ Parent | on HN ]

Re:Low-dose Hydroxychloroquine Therapy and Mortality in Hosp... by lucd on Tuesday August 25, 2020 @02:05PM (#24274129)

Yes mean difference −4.5 days,with a low certainty.. They also say: Hydroxychloroquine might increase the risk of adverse events compared with the other interventions And no evidence for reduction in death, except for glucocorticoids.. I would expect an effective treatment to reduce mortality..

[ Parent | on HN ]